Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

EMORY UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1836-12-10

Employees: 10K

Market Cap: -

Website: http://www.emory.edu

Clinical Trials

Pembrolizumab as Salvage Therapy for the Treatment of Multiple Myeloma in Patients Progressing on CAR-T Cell Therapy

Phase 2

Withdrawn

Conditions: Plasma Cell Myeloma

Interventions: Biological: Pembrolizumab

First Posted Date: 2022-01-24

Last Posted Date: 2024-07-03

Lead Sponsor: Emory University

Registration Number: NCT05204160

Locations: 🇺🇸
Emory University, Atlanta, Georgia, United States

Stress in Inflammatory Bowel Disease

Not Applicable

Completed

Conditions: Inflammatory Bowel Diseases
Psychological

Interventions: Behavioral: Biofeedback Enhanced Treatment

First Posted Date: 2022-01-21

Last Posted Date: 2025-04-22

Lead Sponsor: Emory University

Target Recruit Count: 53

Registration Number: NCT05202418

Locations: 🇺🇸
Atlanta Metropolitan Area, Atlanta, Georgia, United States
🇺🇸
Children's Healthcare of Atlanta, Atlanta, Georgia, United States
🇺🇸
Emory Children's Center Building, Atlanta, Georgia, United States

Improving Sleep and Cognition in Alzheimer's Disease

Not Applicable

Recruiting

Conditions: Alzheimer Disease

Interventions: Dietary Supplement: Citicoline supplement
Other: Placebo

First Posted Date: 2022-01-20

Last Posted Date: 2024-01-10

Lead Sponsor: Emory University

Target Recruit Count: 20

Registration Number: NCT05200208

Locations: 🇺🇸
Emory University School of Nursing, Atlanta, Georgia, United States
🇺🇸
Goizueta Alzheimer's Disease Research Center, Atlanta, Georgia, United States

Medial Peel Release Technique TKA Randomized Clinical Trial

Not Applicable

Terminated

Conditions: Total Knee Arthroplasty
Osteoarthritis, Knee

Interventions: Procedure: Medial Subperiosteal Release with Electrocautery
Procedure: Medial Subperiosteal Release with Sharp Dissection

First Posted Date: 2021-12-10

Last Posted Date: 2023-10-27

Lead Sponsor: Emory University

Target Recruit Count: 4

Registration Number: NCT05154058

Locations: 🇺🇸
Emory Orthopaedics and Spine Center, Atlanta, Georgia, United States

DECIDE: Dyads and Families

Not Applicable

Recruiting

Conditions: Caregiver Burden
Alzheimer Disease
Dementia

Interventions: Behavioral: Prototype Intervention

First Posted Date: 2021-12-01

Last Posted Date: 2025-07-03

Lead Sponsor: Emory University

Target Recruit Count: 40

Registration Number: NCT05139290

Locations: 🇺🇸
Zeta Phi Beta Sorority, Inc., Washington, District of Columbia, United States
🇺🇸
Emory Healthcare Integrated Memory Care Clinic, Atlanta, Georgia, United States
🇺🇸
Emory University Goizueta Alzheimer's Disease Research Center Minority Engagement Core, Atlanta, Georgia, United States

and more 1 locations

Plastic Waste and Human Health Effects in Guatemala

Not Applicable

Suspended

Conditions: Environmental Exposure

Interventions: Behavioral: The community working group

First Posted Date: 2021-11-23

Last Posted Date: 2025-06-19

Lead Sponsor: Emory University

Target Recruit Count: 400

Registration Number: NCT05130632

Locations: 🇬🇹
Universidad del Valle de Guatemala, Guatemala, Guatemala
🇬🇹
Project Office, Jalapa, Jalapa, Guatemala

Botulinum Toxin in Raynaud's Phenomenon

Phase 4

Recruiting

Conditions: Raynaud Phenomenon

Interventions: Drug: Botulinum toxin

First Posted Date: 2021-11-18

Last Posted Date: 2025-02-12

Lead Sponsor: Emory University

Target Recruit Count: 36

Registration Number: NCT05125029

Locations: 🇺🇸
Emory University Hospital, Atlanta, Georgia, United States

Assessment of Consciousness States with NextSense Ear Bud Devices

Not Applicable

Completed

Conditions: Sleep

Interventions: Device: NextSense EEG-enabled earbuds
Device: Ellcie Healthy Glasses

First Posted Date: 2021-11-10

Last Posted Date: 2025-02-11

Lead Sponsor: Emory University

Target Recruit Count: 16

Registration Number: NCT05114616

Locations: 🇺🇸
Emory Sleep Center, Atlanta, Georgia, United States

Mental Health Resources for Frontline Healthcare Workers

Not Applicable

Completed

Conditions: Mental Health

Interventions: Behavioral: Messy Memories App

First Posted Date: 2021-11-09

Last Posted Date: 2025-04-23

Lead Sponsor: Emory University

Target Recruit Count: 53

Registration Number: NCT05113316

Locations: 🇺🇸
12 Executive Park, Atlanta, Georgia, United States

Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant

Phase 2

Recruiting

Conditions: Recurrent Hepatocellular Carcinoma
Stage III Hepatocellular Carcinoma AJCC V8
Stage IIIA Hepatocellular Carcinoma AJCC V8
Stage IIIB Hepatocellular Carcinoma AJCC V8
Stage IV Hepatocellular Carcinoma AJCC V8
Stage IVA Hepatocellular Carcinoma AJCC V8
Stage IVB Hepatocellular Carcinoma AJCC V8
Unresectable Hepatocellular Carcinoma

Interventions: Other: Laboratory Biomarker Analysis
Drug: Lenvatinib

First Posted Date: 2021-11-02

Last Posted Date: 2024-12-27

Lead Sponsor: Emory University

Target Recruit Count: 19

Registration Number: NCT05103904

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸
Mayo Clinic Arizona, Scottsdale, Arizona, United States
🇺🇸
Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy